Drugs / glyceryl trierucate/glyceryl trioleate
last change Dec 2014 re-read 3 minutes ago

glyceryl trierucate/glyceryl trioleate

Developed for
adrenoleukodystrophy
Investigated by
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Trials 1

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00004418 Apr 1998 → Dec 2014 adrenoleukodystrophy Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Terminated No outcome recorded Stop: Business

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as glyceryl trierucate/glyceryl trioleate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004418 ↗
Route Oral “taken orally” NCT00004418 ↗